The Indiana University Cancer Center became an NCI-designated cancer center
In 1999, The Indiana University (IU) Cancer Center became an National Cancer Institute (NCI)-designated cancer center. Its mission…
In 1999, The Indiana University (IU) Cancer Center became an National Cancer Institute (NCI)-designated cancer center. Its mission…
In 1999, the Hudson-Webber Cancer Research Center opened to serve as a ‘translational’ research facility, bridging the gaps…
In 1999, Timothy J. Eberlein, MD was named director of the Alvin J. Siteman Cancer Center. As director…
In 1999, Siteman Cancer Center investigators joined the STAR (Study of Tamoxifen and Raloxifene) trial for breast cancer…
In 1999, the Eppley Cancer Center became a National Cancer Institute (NCI) designated cancer center. NCI grant funding…
On Jan. 1, 1999, HIV infection in adults (clients 13 years of age or older) became reportable by…
In 1999, American Association for Cancer Research (AACR) Scientist-Survivor Program which united researchers with patients and survivor advocates…
In 1999, ClinicalTrials.gov was founded as an Internet-based resource that provide information about clinical research studies to the…
In 1999, the Vancouver Prostate Centre received a $20 million donation by Vancouver businessman Jim Pattison, the largest…
In 1999, Michael Smith, recipient of the 1993 Nobel Prize in Chemistry, founded Canada’s Michael Smith Genome Science…
In 1999, University of California at San Francisco Cancer Research Institute received NCI Comprehensive Cancer Center designation. The…
On Oct. 30, 1999, Livermore National Lab work completed work on the mouse genome as part of Laboratory…
In 1999, the Del E. Webb Center for Neuroscience and Aging, which focuses on diseases such as stroke,…
In 1999, the Delaware Biotechnology Institute was founded as a partnership among government, academia and industry to help…
In 1999, the U.S. Centers for Disease Control and Prevention (CDC) launched the National Pharmaceutical Stockpile, now the…
In 1999, the U.S. Centers for Disease Control and Prevention (CDC) established the Laboratory Response Network (LRN). The…
In 1999, Trubion Pharmaceutical was founded in Seattle as a spin-off from the Pacific Northwest Diabetes Research Institute,…
On Dec. 22, 1998, Washington University – St. Louis researcher Jeffrey I. Gordon, MD and colleagues developed a…
On Oct. 30, 1998, Peter Eriksson of the Salk Institute and Fred Gage of the Sahlgrenska University Hospital…
On Oct. 12, 1998, Louis J. Ignarro of the University of California School of Medicine was awarded the…
In Oct. 1998, the Fetal Alcohol Syndrome Surveillance Network was created to determine the prevalence of FAS within…
On Sept. 25, 1998, the U.S. Food and Drug Administration (FDA) approved the monoclonal antibody Herceptin (Trastuzumab) for…
On Sept. 14, 1998, researchers from the Breast Cancer Prevention Trial (BCPT) published a full report and update…
On Jul. 29, 1998, the Stamp Out Breast Cancer stamp was first issued. The driving force behind the…
On Jul. 15, 1998, Aptein, founded by Glenn Kawasaki in Seattle, was acquired by Cambridge Antibody Technology (CAT)…
On April 30, 1998, the Food and Drug Administration (FDA) approved the Genentech’s drug Xeloda (capecitabine) for the…
In March 1998, the Stop TB Initiative was established following a meeting of the First Ad hoc Committee…
On Feb. 10, 1998, the Cook County Board of Commissioners took the final steps in the approval process,…
On Jan. 13, 1998, Seattle Genetics (Seagen) was founded in Bothell as a biotechnology company focused on developing…
In 1998, the Cystic Fibrosis Research Center was founded at University of Iowa’s College of Medicine. Today, the…